TY - JOUR
T1 - Both Preoperative Perinuclear Antineutrophil Cytoplasmic Antibody and Anti-CBir1 Expression in Ulcerative Colitis Patients Influence Pouchitis Development After Ileal Pouch-Anal Anastomosis
AU - Fleshner, Phillip
AU - Ippoliti, Andrew
AU - Dubinsky, Marla
AU - Vasiliauskas, Eric
AU - Mei, Ling
AU - Papadakis, Konstantinos A.
AU - Rotter, Jerome I.
AU - Landers, Carol
AU - Targan, Stephan
PY - 2008/5
Y1 - 2008/5
N2 - Background & Aims: Acute pouchitis (AP) and chronic pouchitis (CP) are common after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis. The aim of this study was to assess associations of preoperative perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-CBir1 flagellin on AP or CP development. Methods: Patients were assessed prospectively for clinically and endoscopically proven AP (antibiotic responsive) or CP (antibiotic-dependent or refractory to antibiotic therapy). Sera from 238 patients were analyzed for ANCA and anti-CBir1 using an enzyme-linked immunosorbent assay. pANCA+ patients were substratified into high-level (>100 EU/mL) and low-level (<100 EU/mL) groups. Results: After a median follow-up period of 47 months, 72 patients (30%) developed pouchitis. Pouchitis developed in 36% of pANCA+ patients versus 16% of pANCA- patients (P = .005), 46% of anti-CBir1+ patients versus 26% of anti-CBir1- patients (P = .02), and 54% of 35 pANCA+/anti-CBir1+ patients versus 31% of 136 pANCA+/anti-CBir1- patients (P = .02). AP developed in 37 pANCA+ patients (22%) versus 6 pANCA- patients (9%) (P = .02), and 12 anti-CBir1+ patients (26%) versus 31 anti-CBir1- patients (16%) (P = .1). Although AP was not influenced by pANCA level, AP was seen in 38% of low-level pANCA+/anti-CBir1+ patients versus 18% low-level pANCA+/anti-CBir1- patients (P = .03). CP was seen in 29% of high-level pANCA+ patients versus 11% of low-level pANCA+ patients (P = .03). Conclusions: Both pANCA and anti-CBir1 expression are associated with pouchitis after IPAA. Anti-CBir1 increases the incidence of AP only in patients who have low-level pANCA expression, and increases the incidence of CP only in patients who have high-level pANCA expression. Diverse patterns of reactivity to microbial antigens may manifest as different forms of pouchitis after IPAA.
AB - Background & Aims: Acute pouchitis (AP) and chronic pouchitis (CP) are common after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis. The aim of this study was to assess associations of preoperative perinuclear antineutrophil cytoplasmic antibody (pANCA) and anti-CBir1 flagellin on AP or CP development. Methods: Patients were assessed prospectively for clinically and endoscopically proven AP (antibiotic responsive) or CP (antibiotic-dependent or refractory to antibiotic therapy). Sera from 238 patients were analyzed for ANCA and anti-CBir1 using an enzyme-linked immunosorbent assay. pANCA+ patients were substratified into high-level (>100 EU/mL) and low-level (<100 EU/mL) groups. Results: After a median follow-up period of 47 months, 72 patients (30%) developed pouchitis. Pouchitis developed in 36% of pANCA+ patients versus 16% of pANCA- patients (P = .005), 46% of anti-CBir1+ patients versus 26% of anti-CBir1- patients (P = .02), and 54% of 35 pANCA+/anti-CBir1+ patients versus 31% of 136 pANCA+/anti-CBir1- patients (P = .02). AP developed in 37 pANCA+ patients (22%) versus 6 pANCA- patients (9%) (P = .02), and 12 anti-CBir1+ patients (26%) versus 31 anti-CBir1- patients (16%) (P = .1). Although AP was not influenced by pANCA level, AP was seen in 38% of low-level pANCA+/anti-CBir1+ patients versus 18% low-level pANCA+/anti-CBir1- patients (P = .03). CP was seen in 29% of high-level pANCA+ patients versus 11% of low-level pANCA+ patients (P = .03). Conclusions: Both pANCA and anti-CBir1 expression are associated with pouchitis after IPAA. Anti-CBir1 increases the incidence of AP only in patients who have low-level pANCA expression, and increases the incidence of CP only in patients who have high-level pANCA expression. Diverse patterns of reactivity to microbial antigens may manifest as different forms of pouchitis after IPAA.
UR - http://www.scopus.com/inward/record.url?scp=43049128099&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43049128099&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2008.01.002
DO - 10.1016/j.cgh.2008.01.002
M3 - Article
C2 - 18378498
AN - SCOPUS:43049128099
SN - 1542-3565
VL - 6
SP - 561
EP - 568
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 5
ER -